Flu season visitor restriction – age 16 or older (Restricción de visitantes durante la Temporada de Influenza (Flu) – Mayores de 16 años.)

Flu Season Visitor Restriction

Visitors temporarily restricted to age 16 or older

As a safety first organization, Christiana Care is implementing a temporary visitation age restriction starting Friday, Jan. 18. This temporary restriction protects patients, their loved ones and health care workers during this time of extremely high number of influenza cases and other respiratory illnesses circulating in our community.

The new restrictions limit visitors to patients in Christiana and Wilmington hospitals to persons age 16 or older. Children and teens younger than 16 years are most likely to get the flu and remain contagious longer than adults. This restriction does not apply to outpatient and ambulatory services. We began restricting visitors under the age of 16 years in our Neonatal Intensive Care Unit (NICU) and Women’s and Children’s areas on Jan. 18.

Thank you for your understanding and cooperation.

For more information about the Flu visit our Health Library.


Restricción de visitantes durante la Temporada de Influenza (Flu)

Temporalmente solo se permiten los visitantes mayores de 16 años.

Como una organización que promueve la seguridad ante todo, Christiana Care está implementando una restricción temporal en la edad de visitantes a partir del viernes 18 de enero. Esta restricción temporal protege a los pacientes, a sus seres queridos y al personal de cuidados de salud durante esta época con un número extremadamente alto de casos de influenza y de otras enfermedades respiratorias que circulan en nuestra comunidad.

Las nuevas restricciones, en los hospitales Christiana y Wilmington, sólo permiten visitas a pacientes de personas mayores de 16 años. Los niños y adolescentes menores de 16 años son más propensos a contraer el flu y son contagiosos por más tiempo que los adultos. Esta restricción no aplica a las áreas de servicios ambulatorios. Comenzamos la restricción de visitas a menores de 16 años en nuestra Unidad de Cuidados Intensivos Neonatales (NICU) y en las áreas para Mujeres y Niños desde el 18 de enero.

Gracias por su comprensión y cooperación.

Para más información sobre la gripe, visite nuestra Biblioteca de Salud.

Cancer Research at the
Helen F. Graham Cancer Center
& Research Institute

NCORP and Pharmaceutical Clinical Trials

NCORP Clinical Trials

In 1987, Christiana Care was awarded funding as a Community Clinical Oncology Program (CCOP), which provided the opportunity for physicians throughout Delaware to enroll patients in national clinical trials. Additionally, it offered an opportunity to increase minority and underserved community clinical trial participation. Since joining CCOP, the Helen F. Graham Cancer Center & Research Institute has become one of the largest clinical trial programs among community-based hospitals in the country, with some 100 active clinical trials in most kinds of cancer. The Graham Cancer Center is also one of the top enrollers in cancer clinical trials.

In 2014, a number of CCOP’s merged to form NCORP, the National Cancer Institute’s Community Oncology Research Program. NCORP is a national network of investigators, cancer care providers, academic institutions, and other organizations. NCORP continues the work of CCOP’s by offering multi-site cancer clinical trials and studies to diverse populations in community-based healthcare systems across the United States and Puerto Rico. The goal of NCORP is to bring cancer clinical trials – cancer control, prevention, screening, treatment, and imaging – as well as cancer care delivery research, to individuals in their own communities, thus generating a broadly applicable evidence base that contributes to improved patient outcomes and a reduction in cancer disparities.

The mission of the Graham Cancer Center is to reduce the incidence, morbidity and mortality of cancer in our community and to improve quality of life for those living with cancer. Participation in NCORP helps us to realize these goals.

Pharmaceutical Clinical Trials

The Graham Cancer Center offers a robust pharmaceutical trials program that conducts Phase I, II and III chemotherapy and immunotherapy trials in collaboration with private industry and university research centers across the country. Many of these studies give our patients the opportunity for leading-edge cancer treatments, tailored to their particular cancer without leaving our community.

Cancer Research Program
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
For more information, call 302-623-4450 or e-mail us.